AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,009,000 | +335.1% | 464,696 | +111.1% | 0.02% | +300.0% |
| Q2 2020 | $3,679,000 | -40.8% | 220,159 | -48.9% | 0.01% | -64.3% |
| Q1 2020 | $6,218,000 | +431.0% | 431,241 | +1132.1% | 0.01% | +1300.0% |
| Q4 2019 | $1,171,000 | -78.1% | 35,000 | -86.3% | 0.00% | -87.5% |
| Q3 2019 | $5,338,000 | +85.4% | 254,928 | +141.5% | 0.01% | +100.0% |
| Q3 2018 | $2,879,000 | -8.2% | 105,551 | -9.5% | 0.00% | 0.0% |
| Q2 2018 | $3,136,000 | -46.8% | 116,626 | -37.0% | 0.00% | -50.0% |
| Q1 2018 | $5,893,000 | +132.4% | 185,136 | +81.0% | 0.01% | +100.0% |
| Q3 2017 | $2,536,000 | – | 102,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |